ACVRL1 and hereditary hemorrhagic telangiectasia: Also, in 7 out of 9 individuals with ACVRL1 mutations in the French registry of PAH patients, the diagnosis of PAH preceded that of HHT (Girerd et al., 2010), suggesting that ACVRL1 mutations may predispose to HHT or PAH.